- $14.01bn
- $13.69bn
- $880.58m
Annual cashflow statement for Nova, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 93.1 | 140 | 136 | 184 | 259 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 15.7 | 24.1 | 18.3 | 22.3 | 3.9 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 17.5 | -45.7 | -41.1 | 21.5 | -26.1 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 132 | 120 | 124 | 235 | 246 |
| Capital Expenditures | -4.82 | -21.3 | -17.2 | -17.2 | -27.7 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -234 | -78.9 | -108 | -119 | -809 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Cash from Investing Activities | -239 | -100 | -125 | -136 | -837 |
| Financing Cash Flow Items | — | -8.48 | 0 | 0 | -21 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.011 | -29.8 | 0.01 | -48.3 | 642 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -106 | -15 | -4.15 | 50.2 | 57 |